A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at...
We are impressed by the terrific work of the Coalition for Life Course Immunization (CLCI) and want to spread their call to action for improving European health. CLCI understands the importance of a systematic, data...
Nine out of 10 U.S. academic scientists surveyed believe scientists have a part to play in reducing vaccine hesitancy among the public, a research team from Arizona State University’s Center for Science, Technology and...
In a recent study posted to the Preprints with The Lancet / SSRN´s First Look* preprint server, researchers explored national surveillance for new diseases in different countries. Novel pathogen-induced pandemics have...
A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them...
Roughly six decades after the first attempt to develop a vaccine for respiratory syncytial virus, the Food and Drug Administration is poised to approve several shots by next winter. No RSV vaccine has ever been approved...
As of late September 2022, nearly 78% of U.S. adults but only 31% of children ages 5 to 11 had completed their primary series of vaccinations against COVID-19, according to health authorities. In an open-access article...
New analysis by scientists at Scripps Research and University of Brussels finds that climate change and other factors could soon make deadly Lassa fever a much bigger public health problem in Africa In the study, which...
Health officials in New York announced a vaccine-derived poliovirus type 2 case, which involves a person in Rockland County, prompting a vaccination push for the unimmunized and those who aren’t fully protected...
Last week saw increasing transmission of COVID-19 in the majority of countries in the WHO European Region, with 1.6 million new cases and close to 24 000 deaths. The Region remains the second most affected by SARS-CoV-2...